Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity
暂无分享,去创建一个
F. Kirchhoff | B. Hahn | J. Richard | J. Prévost | H. Medjahed | G. Gendron-Lepage | A. Finzi | D. Sauter | M. Benlarbi | C. Bourassa | L. Marchitto | Jérémie Prévost | Lorie Marchitto | Jade Descôteaux-Dinelle | Annemarie Laumaea | Mehdi Benlarbi
[1] Son Thanh Nguyen,et al. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir , 2022, bioRxiv.
[2] B. Haynes,et al. HIV-1 Vpu restricts Fc-mediated effector functions in vivo , 2022, bioRxiv.
[3] J. Kappes,et al. Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell , 2021, bioRxiv.
[4] J. Sodroski,et al. Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir. , 2021, Cell host & microbe.
[5] Genny Del Zotto,et al. Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy , 2020, Cells.
[6] D. Kaufmann,et al. HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells , 2020, Journal of Virology.
[7] Brennan S. Dirk,et al. Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses , 2019, mBio.
[8] Domènec Farré,et al. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor , 2019, PLoS pathogens.
[9] J. Kappes,et al. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses , 2018, Journal of Virology.
[10] D. Kaufmann,et al. Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses , 2018, mBio.
[11] D. Kaufmann,et al. Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals. , 2018, Virology.
[12] F. Kirchhoff,et al. Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo. , 2018, Cell host & microbe.
[13] D. Kaufmann,et al. Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity , 2017, Journal of Virology.
[14] Domènec Farré,et al. Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion , 2017, European journal of immunology.
[15] J. Sodroski,et al. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses , 2017, Journal of Virology.
[16] S. Kent,et al. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity. , 2016, AIDS research and human retroviruses.
[17] G. Learn,et al. The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild. , 2016, Cell host & microbe.
[18] F. Kirchhoff,et al. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance , 2016, mBio.
[19] V. Planelles,et al. CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells. , 2016, AIDS research and human retroviruses.
[20] A. Chakraborty,et al. Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo , 2016, Science.
[21] H. Mouquet,et al. Elimination of HIV-1-infected cells by broadly neutralizing antibodies , 2016, Nature Communications.
[22] O. Mandelboim,et al. The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity , 2016, Oncotarget.
[23] B. Walker,et al. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity , 2015, Journal of Virology.
[24] F. Kirchhoff,et al. A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies , 2015, Journal of Virology.
[25] M. Colonna,et al. DNAM-1 controls NK cell activation via an ITT-like motif , 2015, The Journal of experimental medicine.
[26] Domènec Farré,et al. Signaling Lymphocytic Activation Molecule Family Receptor Homologs in New World Monkey Cytomegaloviruses , 2015, Journal of Virology.
[27] S. Neil,et al. Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors , 2015, PLoS pathogens.
[28] J. Sodroski,et al. CD4 mimetics sensitize HIV-1-infected cells to ADCC , 2015, Proceedings of the National Academy of Sciences.
[29] J. Overbaugh,et al. Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality. , 2015, Cell host & microbe.
[30] M. Schindler,et al. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes , 2015, Journal of Virology.
[31] J. Richard,et al. Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay. , 2014, Journal of visualized experiments : JoVE.
[32] U. Schubert,et al. HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain. , 2014, Virology.
[33] M. Nussenzweig,et al. Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice , 2014, Cell.
[34] E. Boritz,et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression , 2014, Nature.
[35] S. López-Vergès,et al. NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells , 2014, Front. Immunol..
[36] D. Burton,et al. Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity , 2014, Proceedings of the National Academy of Sciences.
[37] D. Fierer,et al. HIV-1 Vpu Antagonism of Tetherin Inhibits Antibody-Dependent Cellular Cytotoxic Responses by Natural Killer Cells , 2014, Journal of Virology.
[38] Domènec Farré,et al. Cytomegalovirus m154 Hinders CD48 Cell-Surface Expression and Promotes Viral Escape from Host Natural Killer Cell Control , 2014, PLoS pathogens.
[39] J. Sodroski,et al. Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity , 2013, Journal of Virology.
[40] H. Ding,et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha , 2013, Retrovirology.
[41] É. Cohen,et al. The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. , 2013 .
[42] E. Haddad,et al. Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice , 2013, Retrovirology.
[43] Frank Kirchhoff,et al. HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A. , 2013, Virology.
[44] Feng Gao,et al. Phenotypic properties of transmitted founder HIV-1 , 2013, Proceedings of the National Academy of Sciences.
[45] Sumati Rajagopalan,et al. Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.
[46] T. Friedrich,et al. Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques , 2013, Journal of Virology.
[47] G. Learn,et al. Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein , 2012, PLoS pathogens.
[48] Jerome H. Kim,et al. Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family , 2012, Journal of Virology.
[49] A. Trkola,et al. ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge , 2012, PLoS pathogens.
[50] J. Overbaugh,et al. HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads , 2012, PLoS pathogens.
[51] G. Learn,et al. Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation. , 2012, The Journal of clinical investigation.
[52] G. Pietersz,et al. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond , 2012, Nature Reviews Drug Discovery.
[53] Mamoru Ito,et al. Vpu Augments the Initial Burst Phase of HIV-1 Propagation and Downregulates BST2 and CD4 in Humanized Mice , 2012, Journal of Virology.
[54] A. Santoni,et al. The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR , 2012, Journal of Virology.
[55] H. Ding,et al. Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages , 2011, Journal of Virology.
[56] E. Campbell,et al. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. , 2010, Cell host & microbe.
[57] J. Richard,et al. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. , 2010, Blood.
[58] G. Learn,et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. , 2009, Cell host & microbe.
[59] E. Zimmerman,et al. HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response , 2009, PLoS pathogens.
[60] A. Moses,et al. Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism , 2009, Journal of Virology.
[61] A. Perelson,et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.
[62] H. Agut,et al. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells , 2009, AIDS.
[63] R. Benarous,et al. Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking , 2009, PLoS pathogens.
[64] Mila Lebedeva,et al. Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.
[65] Lewis L Lanier,et al. Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.
[66] Marc C. Johnson,et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. , 2008, Cell host & microbe.
[67] P. Bieniasz,et al. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.
[68] P. Sharp,et al. Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. , 2007, Virology.
[69] J. Ward,et al. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. , 2007, Blood.
[70] Z. Weng,et al. Generation of Infectious Molecular Clones of Simian Immunodeficiency Virus from Fecal Consensus Sequences of Wild Chimpanzees , 2007, Journal of Virology.
[71] Eric O Long,et al. Activation, coactivation, and costimulation of resting human natural killer cells , 2006, Immunological reviews.
[72] C. Watzl,et al. Molecular Analysis of NTB-A Signaling: A Role for EAT-2 in NTB-A-Mediated Activation of Human NK Cells1 , 2006, The Journal of Immunology.
[73] C. Watzl,et al. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells. , 2006, International immunology.
[74] David M. Rocke,et al. Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection , 2005, Journal of Virology.
[75] Peter D. Kwong,et al. Antigenic conservation and immunogenicity of the HIV coreceptor binding site , 2005, The Journal of experimental medicine.
[76] C. Watzl,et al. Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction1 , 2004, The Journal of Immunology.
[77] Eric O Long,et al. Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts , 2002, The Journal of experimental medicine.
[78] J. Clements,et al. Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. , 2002, AIDS research and human retroviruses.
[79] Massimo Morra,et al. Structural basis for the interaction of the free SH2 domain EAT‐2 with SLAM receptors in hematopoietic cells , 2001, The EMBO journal.
[80] L. Notarangelo,et al. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.
[81] M. Colonna,et al. Patients with X‐linked lymphoproliferative disease have a defect in 2B4 receptor‐mediated NK cell cytotoxicity , 2000, European journal of immunology.
[82] Eric O Long,et al. Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244)1 , 2000, The Journal of Immunology.
[83] L. Notarangelo,et al. X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .
[84] R. Biassoni,et al. 2B4 functions as a co‐receptor in human NK cell activation , 2000, European journal of immunology.
[85] R. Haubrich,et al. Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. , 1999, The Journal of infectious diseases.
[86] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[87] S. Tangye,et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.
[88] M. Colonna,et al. Activating interactions in human NK cell recognition: the role of 2B4‐CD48 , 1999, European journal of immunology.
[89] W. Greene,et al. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor , 1998, Current Biology.
[90] J. Yewdell,et al. CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.
[91] D. Thomas,et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.
[92] J. Margolick,et al. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. , 1996, Journal of immunology.
[93] T. Mcclanahan,et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. , 1996, Immunity.
[94] A. Purohit,et al. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.
[95] M. Amiot,et al. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. , 1991, Journal of immunology.
[96] W. O'brien,et al. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain , 1990, Nature.
[97] Andreas Meyerhans,et al. Genetic organization of a chimpanzee lentivirus related to HIV-1 , 1990, Nature.
[98] I Quinti,et al. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. , 1990, The Journal of infectious diseases.
[99] J. Lawrence,et al. Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23 , 1989, The Journal of experimental medicine.
[100] A. Santoni,et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. , 2007, The Journal of general virology.
[101] Eric O Long,et al. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. , 2006, Blood.
[102] R. Biassoni,et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.